Thomas Baranek

3.2k total citations
42 papers, 2.2k citations indexed

About

Thomas Baranek is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Thomas Baranek has authored 42 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Thomas Baranek's work include Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (7 papers). Thomas Baranek is often cited by papers focused on Immune Cell Function and Interaction (15 papers), T-cell and B-cell Immunology (12 papers) and Immunotherapy and Immune Responses (7 papers). Thomas Baranek collaborates with scholars based in France, Germany and United States. Thomas Baranek's co-authors include Marc Dalod, Karine Crozat, Thien‐Phong Vu Manh, Rachel Guiton, Hassan Jomaa, Andreas Schindler, Peter G. Kremsner, Jochen Wiesner, Mustapha Si‐Tahar and Isabelle Schwartz-Cornil and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and Nature Immunology.

In The Last Decade

Thomas Baranek

40 papers receiving 2.2k citations

Peers

Countries citing papers authored by Thomas Baranek

Since Specialization

Citations

This map shows the geographic impact of Thomas Baranek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Baranek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Baranek more than expected).

Fields of papers citing papers by Thomas Baranek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Baranek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Baranek. The network helps show where Thomas Baranek may publish in the future.

Co-authorship network of co-authors of Thomas Baranek

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Baranek. A scholar is included among the top collaborators of Thomas Baranek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Baranek. Thomas Baranek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Results of the Prospective Randomized UroFollow Trial Comparing Marker-guided Versus Cystoscopy-based Surveillance in Patients with Low/Intermediate-risk Bladder Cancer 2025 ·European Urology Oncology ·(unknown), (unknown), Florian Roghmann, Nicolas von Landenberg, Joachim Noldus, (unknown), (unknown), Oliver W. Hakenberg, Peter J. Goebell, Jörg Hennenlotter, (unknown), (unknown), (unknown), G. Schiffhorst, Thomas Baranek, (unknown)	0
2	Description of a Murine Model of Pneumocystis Pneumonia 2024 ·Mycopathologia ·(unknown), (unknown), Christelle Parent, Guillaume Désoubeaux, Thomas Baranek	1
3	Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses 2022 ·Nature Immunology ·Mélanie Bruchard, (unknown), (unknown), Caroline Truntzer, Elise Ballot, Romain Boidot, Cindy Racoeur, (unknown), Fanny Chalmin, (unknown), Thomas Baranek, Christophe Paget, Bernhard Ryffel, Cédric Rébé, Catherine Paul, Frédérique Végran, François Ghiringhelli	62
4	Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia 2021 ·European Respiratory Journal ·(unknown), (unknown), (unknown), Antoine Guillon, Adam Lesner, (unknown), Thomas Baranek, Mustapha Si‐Tahar, S. Marchand‐Adam, Dieter E. Jenne, Christophe Paget, Youenn Jouan, Brice Korkmaz	28
5	Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients 2020 ·The Journal of Experimental Medicine ·Youenn Jouan, Antoine Guillon, (unknown), Yonatan Perez, Chloé Boisseau, Stéphan Ehrmann, Marion Ferreira, Thomas Daix, Robin Jeannet, (unknown), Pierre‐François Dequin, Mustapha Si‐Tahar, Thomas Baranek, Christophe Paget	128
6	Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer 2020 ·Journal for ImmunoTherapy of Cancer ·Louis Lantier, (unknown), Anne Di Tommaso, (unknown), Mathieu Epardaud, (unknown), Stéphanie Germon, Françoise Debierre-Grockiego, Marie-Noëlle Mévélec, (unknown), (unknown), (unknown), Florence Velge-Roussel, Céline Beauvillain, Thomas Baranek, (unknown), Thibault Kervarrec, Antoine Touzé, Nathalie Moiré, Isabelle Dimier‐Poisson	13
7	Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response 2019 ·Mucosal Immunology ·Maya Hassane, Youenn Jouan, (unknown), Daphnée Soulard, Chloé Boisseau, (unknown), Emmanuel C. Patin, Nathalie Heuzé‐Vourc'h, Jean‐Claude Sirard, Christelle Faveeuw, François Trottein, Mustapha Si‐Tahar, Thomas Baranek, Christophe Paget	29
8	Thymic Program Directing the Functional Development of γδT17 Cells 2018 ·Frontiers in Immunology ·Youenn Jouan, Emmanuel C. Patin, Maya Hassane, Mustapha Si‐Tahar, Thomas Baranek, Christophe Paget	15
9	Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment 2018 ·Frontiers in Immunology ·(unknown), (unknown), Thomas Baranek, Emilie Dalloneau, Laurie Lajoie, (unknown), Christophe Arnoult, Marie-Véronique Demattei, (unknown), Christelle Parent, Nathalie Heuzé‐Vourc'h, Valérie Gouilleux‐Gruart	23
10	FHL2 Regulates Natural Killer Cell Development and Activation during Streptococcus pneumoniae Infection 2017 ·Frontiers in Immunology ·Thomas Baranek, Eric Morello, (unknown), (unknown), (unknown), (unknown), Anne‐Gaëlle Besnard, Emilie Dalloneau, Antoine Guillon, Pierre‐François Dequin, Émilie Narni-Mancinelli, Éric Vivier, Fabrice Laurent, Wei Yu, Christophe Paget, Mustapha Si‐Tahar	16
11	Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases 2017 ·Biochemical Pharmacology ·(unknown), (unknown), Cécile Croix, Anne‐Sophie Lamort, Sandrine Dallet‐Choisy, S. Marchand‐Adam, Adam Lesner, Thomas Baranek, (unknown), Conni Lauritzen, John Pedersen, Nathalie Heuzé‐Vourc'h, Mustapha Si‐Tahar, Erhan Fıratlı, Dieter E. Jenne, Francis Gauthier, Marshall S. Horwitz, Niels Borregaard, Brice Korkmaz	38
12	Omics to Explore Amyotrophic Lateral Sclerosis Evolution: the Central Role of Arginine and Proline Metabolism 2016 ·Molecular Neurobiology ·Franck Patin, Philippe Corcia, Patrick Vourc’h, Lydie Nadal‐Desbarats, Thomas Baranek, Jean‐François Goossens, Sylviane Marouillat, Anne‐Frédérique Dessein, Amandine Descat, Blandine Madji Hounoum, Clément Bruno, Samuel Leman, Christian Andrés, Hélène Blasco	41
13	Combined Metabolomics and Transcriptomics Approaches to Assess the IL-6 Blockade as a Therapeutic of ALS: Deleterious Alteration of Lipid Metabolism 2016 ·Neurotherapeutics ·Franck Patin, Thomas Baranek, Patrick Vourc’h, Lydie Nadal‐Desbarats, Jean‐François Goossens, Sylviane Marouillat, Anne‐Frédérique Dessein, Amandine Descat, Blandine Madji Hounoum, Clément Bruno, Hervé Watier, Mustapha Si‐Tahar, Samuel Leman, Jean‐Claude Lecron, Christian Andrés, Philippe Corcia, Hélène Blasco	35
14	Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence 2015 ·European Respiratory Journal ·Antoine Guillon, Youenn Jouan, (unknown), Fabien Gueugnon, Emilie Dalloneau, Thomas Baranek, (unknown), Eric Morello, Jean‐Christophe Renauld, Muriel Pichavant, Philippe Gosset, Yves Courty, P. Diot, Mustapha Si‐Tahar	35
15	Differential Responses of Immune Cells to Type I Interferon Contribute to Host Resistance to Viral Infection 2012 ·Cell Host & Microbe ·Thomas Baranek, Thien‐Phong Vu Manh, Yannick O. Alexandre, Muhammad Ahmad Maqbool, Joaquin Zacarías-Cabeza, Elena Tomasello, Karine Crozat, Gilles Bessou, Nicolas Zucchini, Scott H. Robbins, Éric Vivier, Ulrich Kalinke, Pierre Ferrier, Marc Dalod	79
16	Natural killer cells in immunodefense against infective agents 2008 ·Expert Review of Anti-infective Therapy ·Nicolas Zucchini, Karine Crozat, Thomas Baranek, Scott H. Robbins, Marcus Altfeld, Marc Dalod	30
17	Elastin Receptor (Spliced Galactosidase) Occupancy by Elastin Peptides Counteracts Proinflammatory Cytokine Expression in Lipopolysaccharide-Stimulated Human Monocytes through NF-κB Down-Regulation 2007 ·The Journal of Immunology ·Thomas Baranek, Romain Debret, Frank Antonicelli, Bouchaïb Lamkhioued, Azzaq Belaaouaj, William Hornebeck, Philippe Bernard, Moncef Guenounou, Richard Le Naour	34
18	TMAZ Nanoparticles as Potential Drugs Influencing the Cellular Signal Transduction Pathways 2005 ·TechConnect Briefs ·(unknown), Thomas Baranek, (unknown), Jörg B. Schulz	1
19	Fosmidomycin‐Clindamycin forPlasmodium falciparumInfections in African Children 2004 ·The Journal of Infectious Diseases ·Steffen Borrmann, Ayôla Akim Adégnika, Pierre‐Blaise Matsiegui, Saadou Issifou, Andreas Schindler, Denise Patricia Mawili-Mboumba, Thomas Baranek, Jochen Wiesner, Hassan Jomaa, Peter G. Kremsner	82
20	Fosmidomycin for malaria 2002 ·The Lancet ·Michel A. Missinou, Steffen Borrmann, Andreas Schindler, Saadou Issifou, Ayôla Akim Adégnika, Pierre‐Blaise Matsiegui, Ronald K. Binder, Bertrand Lell, Jochen Wiesner, Thomas Baranek, Hassan Jomaa, Peter G. Kremsner	175

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact